CNBC-TV18's Ekta Batra reports that Ranbaxy is to receive an USFDA approval for validation for a particular drug on Monday, March 25 after which it would forfeit opportunities to develop the drug
first published: Mar 22, 2013 04:48 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty reclaims 25,300, registers over 1% gain this week | Closing Bell
Live: Will Nifty bulls aim to break 25,250 after strong TCS Q2? | Opening Bell
TCS Q2 Earnings Live: Margin, Revenue Beat Street Estimates
Live: Nifty reclaims 25,100 ahead of TCS Q2 results; pharma, metals shine | Closing Bell
You are already a Moneycontrol Pro user.